P Mlejnek, P Dolezel
Index: Acta Physiol. (Oxf.) 199(2) , 171-9, (2010)
Full Text: HTML
The sensitivity of cancer cells which exhibit multi-drug resistance phenotype to A3 adenosine receptor (A3AR) agonist N(6)-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide (IB-MECA) was studied.To establish direct relationship between P-glycoprotein (P-gp, ABCB1 and MDR1) expression and IB-MECA induced cell death, a straightforward method for precise estimation of intracellular level of this A3AR agonist was developed.We subjected three human leukaemia cell lines HL-60, K562 and K562/HHT to treatment with micromolar concentrations of IB-MECA. Although all cell lines used expressed A3AR, there was a large difference in their sensitivity to IB-MECA. While HL-60 and K562 cells were almost equally sensitive, the K562/HHT cells, which exhibit a multi-drug resistance phenotype because of overexpression of P-gp, were significantly more resistant. We found that the intracellular level of IB-MECA in K562/HHT cells was approx. 10 times lower than those in HL-60 or K562 cells. Inhibitors of P-gp, including cyclosporine A (CsA) and verapamil (Vpa), increased the intracellular level of IB-MECA and reversed the resistance of K562/HHT cells to this drug. Accordingly, shRNA-mediated down-regulation of P-gp significantly increased the intracellular level of IB-MECA in K562/HHT cells which simultaneously exhibited reduced resistance to this A3AR agonist. In addition, an in vitro enzyme-based assay provided evidence that IB-MECA might serve as a substrate for P-gp.Our results suggest that P-gp overexpression prevents cells from IB-MECA induced apoptosis despite the A3AR expression. Pro-apoptotic effect of IB-MECA seemed to strongly depend on its intracellular accumulation rather than on its interaction with A3AR.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
IB-MECA
CAS:152918-18-8 |
C18H19IN6O4 |
Equilibrium and kinetic selectivity profiling on the human a...
2016-04-01 [Biochem. Pharmacol. 105 , 34-41, (2016)] |
Activation of A1, A2A, or A3 adenosine receptors attenuates ...
2010-08-01 [J. Thorac. Cardiovasc. Surg. 140(2) , 440-6, (2010)] |
Activation of adenosine low-affinity A3 receptors inhibits t...
2009-12-01 [Am. J. Physiol. Gastrointest. Liver Physiol. 297(6) , G1147-62, (2009)] |
A role for central A3-adenosine receptors. Mediation of beha...
1993-12-20 [FEBS Lett. 336 , 57-60, (1993)] |
The effects of adenosine A3 receptor stimulation on seizures...
1995-02-24 [Eur. J. Pharmacol. 275 , 23-29, (1995)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved